Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
26.91
+0.15 (0.56%)
At close: Oct 20, 2025, 4:00 PM EDT
27.00
+0.09 (0.33%)
After-hours: Oct 20, 2025, 5:49 PM EDT
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts that cover Janux Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $76.55, which forecasts a 184.47% increase in the stock price over the next year. The lowest target is $41 and the highest is $200.
Price Target: $76.55 (+184.47%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 17, 2025.
Analyst Ratings
The average analyst rating for Janux Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 3 | 3 | 5 | 5 |
| Buy | 3 | 3 | 4 | 4 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 8 | 8 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +74.66% | Sep 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +271.61% | Sep 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +67.22% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +167.56% | Sep 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +56.08% | Aug 19, 2025 |
Financial Forecast
Revenue This Year
2.91M
from 10.59M
Decreased by -72.48%
Revenue Next Year
5.59M
from 2.91M
Increased by 91.66%
EPS This Year
-2.32
from -1.28
EPS Next Year
-3.08
from -2.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5M | 63.2M | |||
| Avg | 2.9M | 5.6M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.8% | 2,067.7% | |||
| Avg | -72.5% | 91.7% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.07 | -1.96 | |||
| Avg | -2.32 | -3.08 | |||
| Low | -3.13 | -5.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.